Probiotics, prebiotics, and synbiotics - PubMed (original) (raw)
Review
Probiotics, prebiotics, and synbiotics
Michael de Vrese et al. Adv Biochem Eng Biotechnol. 2008.
Abstract
According to the German definition, probiotics are defined viable microorganisms, sufficient amounts of which reach the intestine in an active state and thus exert positive health effects. Numerous probiotic microorganisms (e.g. Lactobacillus rhamnosus GG, L. reuteri, bifidobacteria and certain strains of L. casei or the L. acidophilus-group) are used in probiotic food, particularly fermented milk products, or have been investigated--as well as Escherichia coli strain Nissle 1917, certain enterococci (Enterococcus faecium SF68) and the probiotic yeast Saccharomyces boulardii--with regard to their medicinal use. Among the numerous purported health benefits attributed to probiotic bacteria, the (transient) modulation of the intestinal microflora of the host and the capacity to interact with the immune system directly or mediated by the autochthonous microflora, are basic mechanisms. They are supported by an increasing number of in vitro and in vivo experiments using conventional and molecular biologic methods. In addition to these, a limited number of randomized, well-controlled human intervention trials have been reported. Well-established probiotic effects are: 1. Prevention and/or reduction of duration and complaints of rotavirus-induced or antibiotic-associated diarrhea as well as alleviation of complaints due to lactose intolerance. 2. Reduction of the concentration of cancer-promoting enzymes and/or putrefactive (bacterial) metabolites in the gut. 3. Prevention and alleviation of unspecific and irregular complaints of the gastrointestinal tracts in healthy people. 4. Beneficial effects on microbial aberrancies, inflammation and other complaints in connection with: inflammatory diseases of the gastrointestinal tract, Helicobacter pylori infection or bacterial overgrowth. 5. Normalization of passing stool and stool consistency in subjects suffering from obstipation or an irritable colon. 6. Prevention or alleviation of allergies and atopic diseases in infants. 7. Prevention of respiratory tract infections (common cold, influenza) and other infectious diseases as well as treatment of urogenital infections. Insufficient or at most preliminary evidence exists with respect to cancer prevention, a so-called hypocholesterolemic effect, improvement of the mouth flora and caries prevention or prevention or therapy of ischemic heart diseases or amelioration of autoimmune diseases (e.g. arthritis). A prebiotic is "a selectively fermented ingredient that allows specific changes, both in the composition and/or activity in the gastrointestinal microflora that confers benefits upon host well being and health", whereas synergistic combinations of pro- and prebiotics are called synbiotics. Today, only bifidogenic, non-digestible oligosaccharides (particularly inulin, its hydrolysis product oligofructose, and (trans)galactooligosaccharides), fulfill all the criteria for prebiotic classification. They are dietary fibers with a well-established positive impact on the intestinal microflora. Other health effects of prebiotics (prevention of diarrhoea or obstipation, modulation of the metabolism of the intestinal flora, cancer prevention, positive effects on lipid metabolism, stimulation of mineral adsorption and immunomodulatory properties) are indirect, i.e. mediated by the intestinal microflora, and therefore less-well proven. In the last years, successful attempts have been reported to make infant formula more breast milk-like by the addition of fructo- and (primarily) galactooligosaccharides.
Similar articles
- Prebiotic effects: metabolic and health benefits.
Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco MJ, Léotoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck AM, Meheust A. Roberfroid M, et al. Br J Nutr. 2010 Aug;104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363. Br J Nutr. 2010. PMID: 20920376 Review. - Probiotics and prebiotics in pediatrics.
Thomas DW, Greer FR; American Academy of Pediatrics Committee on Nutrition; American Academy of Pediatrics Section on Gastroenterology, Hepatology, and Nutrition. Thomas DW, et al. Pediatrics. 2010 Dec;126(6):1217-31. doi: 10.1542/peds.2010-2548. Epub 2010 Nov 29. Pediatrics. 2010. PMID: 21115585 Review. - Probiotics.
Gupta V, Garg R. Gupta V, et al. Indian J Med Microbiol. 2009 Jul-Sep;27(3):202-9. doi: 10.4103/0255-0857.53201. Indian J Med Microbiol. 2009. PMID: 19584499 Review. - Probiotics and prebiotics in dietetics practice.
Douglas LC, Sanders ME. Douglas LC, et al. J Am Diet Assoc. 2008 Mar;108(3):510-21. doi: 10.1016/j.jada.2007.12.009. J Am Diet Assoc. 2008. PMID: 18313433 Review. - [Probiotics--an alternative for antibiotics?].
Trafalska E, Grzybowska K. Trafalska E, et al. Wiad Lek. 2004;57(9-10):491-8. Wiad Lek. 2004. PMID: 15765768 Review. Polish.
Cited by
- World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update - XI - Milk supplement/replacement formulas for infants and toddlers with CMA - Systematic review.
Bognanni A, Firmino RT, Arasi S, Chu DK, Chu AWL, Waffenschmidt S, Agarwal A, Dziechciarz P, Horvath A, Mihara H, Roldan Y, Terracciano L, Martelli A, Starok A, Said M, Shamir R, Ansotegui IJ, Dahdah L, Ebisawa M, Galli E, Kamenwa R, Lack G, Li H, Pawankar R, Warner A, Wong GWK, Bozzola M, Assa'Ad A, Dupont C, Bahna S, Spergel J, Venter C, Szajewska H, Nowak-Wegrzyn AH, Vandenplas Y, Papadopoulos NG, Waserman S, Fiocchi A, Schünemann HJ, Brożek JL. Bognanni A, et al. World Allergy Organ J. 2024 Sep 10;17(9):100947. doi: 10.1016/j.waojou.2024.100947. eCollection 2024 Sep. World Allergy Organ J. 2024. PMID: 39310372 Free PMC article. - Food Additives' Impact on Gut Microbiota and Metabolic Syndrome: A Systematic Review.
Singh S, Olayinka OT, Fr J, Nisar MR, Kotha R, Saad-Omer SI, Nath TS. Singh S, et al. Cureus. 2024 Aug 13;16(8):e66822. doi: 10.7759/cureus.66822. eCollection 2024 Aug. Cureus. 2024. PMID: 39280570 Free PMC article. Review. - Gut-Brain Axis: Role of Microbiome, Metabolomics, Hormones, and Stress in Mental Health Disorders.
Verma A, Inslicht SS, Bhargava A. Verma A, et al. Cells. 2024 Aug 27;13(17):1436. doi: 10.3390/cells13171436. Cells. 2024. PMID: 39273008 Free PMC article. Review. - Gut microbiome perturbation and its correlation with tylosin pharmacokinetics in healthy and infected pigs.
Lee EB, Lee GY, Hossain MA, Awji EG, Park SC. Lee EB, et al. Sci Rep. 2024 Aug 12;14(1):18670. doi: 10.1038/s41598-024-69566-2. Sci Rep. 2024. PMID: 39134586 Free PMC article. - The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessment.
Maddineni G, Obulareddy SJ, Paladiya RD, Korsapati RR, Jain S, Jeanty H, Vikash F, Tummala NC, Shetty S, Ghazalgoo A, Mahapatro A, Polana V, Patel D. Maddineni G, et al. Ann Med Surg (Lond). 2024 Jun 20;86(8):4714-4731. doi: 10.1097/MS9.0000000000002276. eCollection 2024 Aug. Ann Med Surg (Lond). 2024. PMID: 39118769 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical